Intraday BUY SELL Signals
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
EFAV vs GSK Comparison Chart in %
Loading...
loading
loading
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Jul 10, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a Buy and GSK is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 39 | |
SMR RATING 1..100 | 27 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 75 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 67% | 2 days ago 48% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 82% | N/A |
| TrendWeek ODDS (%) | 2 days ago 76% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 57% |
| Advances ODDS (%) | 3 days ago 77% | 11 days ago 62% |
| Declines ODDS (%) | 9 days ago 75% | 9 days ago 54% |
| BollingerBands ODDS (%) | 2 days ago 67% | N/A |
| Aroon ODDS (%) | 2 days ago 72% | 2 days ago 51% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EZET | 13.25 | 0.07 | +0.53% |
| Franklin Ethereum ETF | |||
| QMAG | 25.39 | 0.10 | +0.40% |
| FT Vest Nasdaq-100 Mod Buffr ETF - Aug | |||
| AVIV | 78.20 | 0.30 | +0.39% |
| Avantis International Large Cap Val ETF | |||
| OIA | 6.19 | 0.02 | +0.32% |
| INVESCO Municipal Income OPPORTUNITIES TRUST | |||
| FMED | 28.25 | N/A | N/A |
| Fidelity Disruptive Medicine ETF | |||
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with SAN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then SAN could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | -0.28% | ||
| SAN - EFAV | 52% Loosely correlated | +1.62% | ||
| RIO - EFAV | 50% Loosely correlated | +0.78% | ||
| GSK - EFAV | 44% Loosely correlated | -0.10% | ||
| RTO - EFAV | 44% Loosely correlated | +0.07% | ||
| MRK - EFAV | 41% Loosely correlated | -0.73% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y